Caplin Point posts stellar results

Rohan Takalkar
Caplin Point posts stellar results

Caplin Point Laboratories consolidated revenue for the quarter came in at Rs. 141.6 crore, registering 37.9 per cent yoy increase and 8 per cent qoq increase.

EBITDA for the quarter rose by 63.7 per cent yoy to Rs. 50.9 crore with a corresponding margin expansion of 566 bps. EBITDA margin for the quarter stood at 35.9 per cent. This margin expansion was aided by lower other expenses to Rs. 15.5 crore in Q3FY18 compared to Rs. 20.78 crore in previous year corresponding quarter.

 The PAT for the quarter came in at Rs. 37.48 crore, yoy increase of 57.5 per cent and qoq increase of 5.6 per cent.

 On Wednesday, the stock opened for trading at Rs. 558 per share and touched high of Rs. 609 before closing at Rs. 590, up by 5.6 per cent

Rate this article:

Leave a comment

This form collects your name, email, IP address and content so that we can keep track of the comments placed on the website. For more info check our Privacy Policy and Terms Of Use where you will get more info on where, how and why we store your data.
Add comment


Mkt Commentary28-Sep, 2022

Mindshare28-Sep, 2022

Mindshare28-Sep, 2022

Multibaggers28-Sep, 2022

Penny Stocks28-Sep, 2022


Tax Column

Tax Column

I am employed with a closely held private limited company. During the current...